Health
Cigarette maker BAT announces US vaccine trial launch – Medical Xpress
British cigarette maker BAT said Wednesday that its US biotech division Kentucky BioProcessing will launch trials of a potential coronavirus vaccine, developed…
British cigarette maker BAT said Wednesday that its US biotech division Kentucky BioProcessing will launch trials of a potential coronavirus vaccine, developed using tobacco plant technology.
The group said the US Food and Drug Administration has approved its application for a vaccine candidate, paving the way for an initial phase one clinical trial in 180 adults.
Study results are expected in mid-2021, when the group hopes to progress to a phase two trial on the project, which is being run on a…
-
Noosa News19 hours agoPolice officer who tracked Toyah Cordingley’s phone gives evidence at Rajwinder Singh’s murder trial
-
General19 hours agoARIA Awards 2025 winners: Amyl & The Sniffers and Ninajirachi dominate
-
Noosa News5 hours agoMotorcyclist dies in crash with truck
-
Noosa News4 hours agoMan charged over allegedly abandoning Arnie the German shepherd in car after claiming dog and vehicle were stolen